future tech posted by

On the biotech border.

Cytos

The folk at Swiss biotech research company Cytos appear to be very busy indeed. Judging by the list of their recent trials.

  • 2005, May 18:  Alzheimer’s
  • 2005, May 14 : Vaccine to treat nicotine addiction
  • 2005, May 11: Obesity vaccine

Cytos Biotechnology AG is a public Swiss biotechnology company engaged in the discovery, development and commercialization of a new class of biopharmaceutical products – the Immunodrugs. Immunodrugs are intended for use in treatment and prevention of common chronic diseases which afflict millions of people worldwide.

Comments are closed.

comments powered by Disqus

Side Advert

Write For Us

Personnel

Managing Editor:
Nigel Powell

Associate Editor:
Caitlyn Muncy
Associate Editor:
Dan Ferris
Ecological Editor:
Debra Atlas
Technology Editor:
Fritz Effenberger
Asian Editor:
Hu Ping
Reviews Editor:
Kevin Evans

FB Like Box